Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy

The mammalian target of rapamycin (mTOR) is a highly conserved serine/threonine-protein kinase, which regulates many biological processes related to metabolism, cancer, immune function, and aging. It is an essential protein kinase that belongs to the phosphoinositide-3-kinase (PI3K) family and has t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouyahya, Abdelhakim, El Allam, Aicha, Aboulaghras, Sara, Bakrim, Saad, El Menyiy, Naoual, Alshahrani, Mohammed Merae, Al Awadh, Ahmed Abdullah, Benali, Taoufiq, Lee, Learn-Han, El Omari, Nasreddine, Goh, Khang Wen, Ming, Long Chiau, Mubarak, Mohammad S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688668/
https://www.ncbi.nlm.nih.gov/pubmed/36428613
http://dx.doi.org/10.3390/cancers14225520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688668/
https://www.ncbi.nlm.nih.gov/pubmed/36428613
http://dx.doi.org/10.3390/cancers14225520

Ejemplares similares